Prognostic factors for ovarian metastases in colorectal cancer patients

被引:3
作者
Chen, Chao [1 ]
Wang, Da [1 ]
Ge, Xiaoxu [1 ,2 ]
Wang, Jian [1 ]
Huang, Yuhuai [1 ]
Ling, Tianyi [1 ]
Jin, Tian [1 ]
Yang, Jinhua [3 ]
Wang, Fengping [3 ]
Wu, Weihong [3 ]
Sun, Lifeng [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent, Dept Colorectal Surg & Oncol,Minist Educ,Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Canc Inst, Hangzhou, Zhejiang, Peoples R China
[3] Changxing Cty Peoples Hosp, Dept Gastrointestinal Surg, Huzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Ovarian metastases; Prognosis factors; Cytoreductive surgery; Scoring system; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; APPENDICEAL; SURVIVAL; OOPHORECTOMY; IMPACT; TUMOR; NOMOGRAM; HIPEC;
D O I
10.1186/s12957-021-02305-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The aim of this study was to analyze prognostic factors for ovarian metastases (OM) in colorectal cancer (CRC) using data from a Chinese center. In addition, the study aimed at developing a new clinical scoring system for prognosis of OM of CRC patients after surgery. Patients and methods Data of CRC patients with OM were collected from a single Chinese institution (n = 67). Kaplan-Meier analysis was used to evaluate cumulative survival of patients. Factors associated with prognosis of overall survival (OS) were explored using Cox's proportional hazard regression models. A scoring system to determine effectiveness of prognosis was developed. Results Median OS values for patients with or without surgery were 22 and 7 months, respectively. Size of OM, number of OM, peritoneal metastasis (PM), Peritoneal cancer index (PCI), and completeness of cytoreduction (CC) were associated with OS of patients through univariate analysis. Multivariate analysis using a Cox regression model showed that only CC was an independent predictor for OS. Three variables (the size of OM >15cm, PCI >= 10, and carcinoembryonic antigen (CEA) >30 ng/mL) assigned one point each were used to develop a risk score. The resulting score was used for prognosis of OS. Conclusion Surgical treatment of metastatic sites is effective and safe for CRC patients with OM. CC-0 is recommended for improved prognosis. The scoring system developed in this study is effective for prediction of OS of patients after surgery.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival
    Al-Busaidi, Ibrahim S.
    Bailey, Teresa
    Dobbs, Bruce
    Eglinton, Tim W.
    Wakeman, Christopher J.
    Frizelle, Frank A.
    [J]. ANZ JOURNAL OF SURGERY, 2019, 89 (09) : 1091 - 1096
  • [2] Peritoneal spillage is not an issue in patients undergoing minimally invasive surgery for colorectal cancer
    Ambe, Peter C.
    Kankam, Joseph
    Zarras, Konstantinos
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [3] Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer
    Bignell, M. B.
    Mehta, A. M.
    Alves, S.
    Chandrakumaran, K.
    Dayal, S. P.
    Mohamed, F.
    Cecil, T. D.
    Moran, B. J.
    [J]. COLORECTAL DISEASE, 2018, 20 (08) : 704 - 710
  • [4] Bray F., 2018, CA Cancer J ClinAnticancer Res, DOI DOI 10.3322/CAAC.21492
  • [5] The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-O4 study
    Byun, Jae Ho
    Ahn, Joong Bae
    Kim, Sun Young
    Kang, Jung Hun
    Zang, Dae Young
    Kang, Seok Yun
    Kang, Myoung Joo
    Shim, Byoung Yong
    Baek, Sun Kyung
    Kim, Bong-Seog
    Lee, Kyung Hee
    Lee, Soon Il
    Cho, Sang-Hee
    Sohn, Byeong Seok
    Kim, Samyong
    Hwang, In Gyu
    Nam, Eun Mi
    Seo, Bong-Gun
    Oh, Sang Cheul
    Lee, Myung-Ah
    Lee, Sang-Cheol
    Hong, Ji Hyung
    Park, Young Suk
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (01) : 165 - 177
  • [6] Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
    Canda, Aras Emre
    Arslan, Cigdem
    Terzi, Cem
    Sokmen, Selman
    Yavuzsen, Tugba
    Ozkardesler, Sevda
    Unlu, Mehtat
    Obuz, Funda
    Fuzun, Mehmet
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [7] Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers An Observational Cohort Study
    Cashin, Peter H.
    Graf, Wilhelm
    Nygren, Peter
    Mahteme, Haile
    [J]. ANNALS OF SURGERY, 2012, 256 (06) : 1078 - 1083
  • [8] Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Chua, Terence C.
    Morris, David L.
    Esquivel, Jesus
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1330 - 1336
  • [9] External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer
    Demey, Karel
    Wolthuis, Albert
    van Overstraeten, Anthony de Buck
    Fieuws, Steffen
    Vandecaveye, Vincent
    Van Cutsem, Eric
    D'Hoore, Andre
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3604 - 3608
  • [10] Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
    Di Giorgio, Angelo
    De Iaco, Pierandrea
    De Simone, Michele
    Garofalo, Alfredo
    Scambia, Giovanni
    Pinna, Antonio Daniele
    Verdecchia, Giorgio Maria
    Ansaloni, Luca
    Macri, Antonio
    Cappellini, Paolo
    Ceriani, Valerio
    Giorda, Giorgio
    Biacchi, Daniele
    Vaira, Marco
    Valle, Mario
    Sammartino, Paolo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 914 - 922